Industry

PARSIPPANY, N.J.–(BUSINESS WIRE)–#ExtremityMedical–Extremity Medical, LLC, a global medical device company focused on the development of innovative implants and instruments for upper and lower extremities, today announced that it has received an award for the Vizient Inc., National Small Joints Category. The awarded contract includes all Extremity Medical’s Upper and Lower Extremity systems, including the innovative … [Read more…]

Medallia joins select group of leading companies focused on elevating humanism in healthcare and improving patient experience PLEASANTON, Calif.–(BUSINESS WIRE)–Medallia, Inc., the global leader in customer and employee experience, today announced its partnership with The Arnold P. Gold Foundation as a Gold Corporate Council Member. The Gold Foundation champions humanism in healthcare, which it defines … [Read more…]

Topline results expected early Q4 2022 `S-HERTOGENBOSCH, Netherlands–(BUSINESS WIRE)–Amphera B.V., a late-stage biotechnology company developing cell therapies to treat cancer, announces that the last patient has completed the active follow-up in the Phase II/III DENIM study of MesoPher cell therapy to treat pleural mesothelioma. Ilona Enninga PhD, COO of Amphera said: “Despite the challenges experienced … [Read more…]

Funding will accelerate development of novel disease-modifying targeted protein degraders against high value precision oncology targets SAN DIEGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Differentiated Therapeutics (dx/tx), a biotech company focused on computationally predicting and optimizing targeted protein degraders (TPDs), today announced the completion of a $5 million Seed financing. Curie.Bio, a founder-focused seed-stage venture capital firm, financed … [Read more…]

ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s second quarter 2022 financial results will be released before market open on Monday, August 8, 2022. LENSAR’s management will host a conference call … [Read more…]

Thermo Scientific Arctis Cryo-Plasma FIB enables speed and consistency of cellular cryo-electron tomography HILLSBORO, Ore.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Thermo Scientific Arctis Cryo-Plasma Focused Ion Beam (Cryo-PFIB), a new connected and automated microscope designed to advance the pace of cryo-electron tomography (cryo-ET) research. Cryo-ET makes it … [Read more…]

Wejo RTTI™ will provide 9-1-1 first responders access to real-time comprehensive traffic data from millions of connected vehicles through Roadside Telematics Corp’s RoadMedic® Next-Generation 9-1-1 Intelligent Crash Data Ecosystem. MANCHESTER, England–(BUSINESS WIRE)–Wejo Group Limited (NASDAQ: WEJO), a global leader in Smart Mobility cloud and software solutions for connected, electric and autonomous vehicle data, today announced … [Read more…]

WOBURN, Mass.–(BUSINESS WIRE)–Covaris, LLC (“Covaris” or “the Company”), a manufacturer of advanced tools enabling life science innovations, announced today that it has appointed Annemarie Watson as Chief Executive Officer, effective immediately. Ms. Watson succeeds Covaris founder Jim Laugharn, who will remain an investor in Covaris and on serve on the Company’s Board of Directors, as … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–$AVRO—AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a shared purpose to free people from a lifetime of genetic disease, today announced that members of its senior management team are scheduled to participate in two upcoming investor conferences: Hybrid BTIG Biotechnology Conference 2022 Dates: Monday, Aug. 8, 2022 – Tuesday, … [Read more…]

Pivotal study follows successful Phase 2 trial, which demonstrated improvements in attention function as compared to both treatment as usual and single task video game groups Pivotal Data Readout expected in 2H2023 BOSTON–(BUSINESS WIRE)–Akili Interactive (“Akili”), a leading digital medicine company, today announced the start of a pivotal Phase 3 randomized, controlled study of SDT-001 … [Read more…]